Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2022 | A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants | Lee, I-Jung; Sun, Cheng-Pu ; Wu, Ping-Yi; Lan, Yu-Hua; Wang, I-Hsuan ; Liu, Wen-Chun ; Yuan, Joyce, Pei-Yi; Chang, Yu-Wei; Tseng, Sheng-Che; Tsung, Szu-I; Chou, Yu-Chi ; Kumari, Monika; Lin, Yin-Shiou; Chen, Hui-Feng; Chen, Tsung-Yen; Lin, Chih-Chao; Chiu, Chi-Wen; Hsieh, Chung-Hsuan; Chuang, Cheng-Ying; Cheng, Chao-Min; Lin, Hsiu-Ting; Chen, Wan-Yu; Hsu, Fu-Fei; Hong, Ming-Hsiang; Liao, Chun-Che ; Chang, Chih-Shin; Liang, Jian-Jong; Ma, Hsiu-Hua; Chiang, Ming-Tsai; Liao, Hsin-Ni; Ko, Hui-Ying; Chen, Liang-Yu; Ko, Yi-An; Yu, Pei-Yu; Yang, Tzu-Jing; Chiang, Po-Cheng; Hsu, Shang-Te ; Lin, Yi-Ling ; Lee, Chong-Chou; Wu, Han-Chung ; Tao, Mi-Hua | Journal of Biomedical Science 29(1), 49 | | | |
2022 | A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies | Kumari, Monika; Lu, Ruei-Min ; Li, Mu-Chun; Huang, Jhih-Liang; Hsu, Fu-Fei; Ko, Shih-Han; Ke, Feng-Yi; Su, Shih-Chieh; Liang, Kang-Hao; Yuan, Joyce Pei-Yi; Chiang, Hsiao-Ling; Sun, Cheng-Pu; Lee, I.-Jung; Li, Wen-Shan ; Hsieh, Hsing-Pang ; Tao, Mi-Hua ; Wu, Han-Chung | Journal of Biomedical Science 29(1), 68 | | | |
2016 | Advancement and applications of peptide phage display technology in biomedical science | Wu, CH; Liu, IJ; Lu, RM ; Wu, HC | Journal of biomedical science 23(1), 8 | | | |
2015 | An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer | Liao, M. Y.; Lai, J. K.; Kuo, M. Y. P.; Lu, R. ; Lin, C. W.; Cheng, P. C.; Liang, K. H.; Wu, H. C. | Oncotarget 6(28), 24947-24968 | | | |
2022 | An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization | Hsu, FF; Liang, KH; Kumari, M; Chen, WY; Lin, HT; Cheng, CM; Tao, MH ; Wu, HC | International Journal of Pharmaceutics 627:122256, 1-10 | | | |
2021 | Antibody cocktail effective against variants of SARS-CoV-2 | Liang, Kang-Hao; Chiang, Pao-Yin; Ko, Shih-Han; Chou, Yu-Chi ; Lu, Ruei-Min ; Lin, Hsiu-Ting; Chen, Wan-Yu; Lin, Yi-Ling ; Tao, Mi-Hua ; Jan, Jia-Tsrong ; Wu, Han-Chung | Journal of biomedical science 28, 80 | | | |
2019 | Antibody-based therapeutics for cancer theranostics | Wu, H. C. | | | | |
2023 | Bivalent mRNA Vaccine Effectiveness against SARS-CoV-2 Variants of Concern | Kumari, M.; Su, S. C.; Liang, K. H.; Lin, H. T.; Lu, Y. F.; Chen, K. C.; Chen, W. Y.; Wu, H. C. | Journal of Biomedical Science 30, 46 | | | |
2023 | Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice | Ruei-Min Lu ; Kang-Hao Liang; Hsiao-Ling Chiang; Fu-Fei Hs; Hsiu-Ting Lin; Wan-Yu Chen; Feng-Yi Ke; Monika Kumari; Yu-Chi Chou ; Mi-Hua Tao ; Yi-Ling Lin ; Han-Chung Wu | Heliyon 9(5), e15587 | | | |
2023 | Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2 | Chiang, H. L.; Liang, K. L.; Lu, R. M. ; Kuo, T. W.; Lin, Y. L. ; Wu, H. C. | Journal of Biomedical Science 30, 59 | | | |
2022 | Collagen-binding peptides for the enhanced imaging, lubrication and regeneration of osteoarthritic articular cartilage | Chin-Yu Lin; Yung-Li Wang; Yu-Jen Chen; Chun-Te Ho; Yi-Hsuan Chi; Long Yi Chan; Guan-Wen Chen; Horng-Chaung Hsu; Dennis W. Hwang ; Han-Chung Wu ; Shih-Chieh Hung | Nature Biomedical Engineering 6, 1105-1117 | | | |
2021 | Combined Effect of Anti-SSEA4 and Anti-Globo H Antibodies on Breast Cancer Cells | R.-H. Lee; Y.-J. Wang; T.-Y. La; T.-L. Hsu ; P.-K. Chuang; H.-C. Wu ; C.-H. Wong | ACS chemical biology 16(8), 1526-1537 | | | |
2020 | CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway | Cheng, Chih-Lun; Yang, Shang-Chih; Lai, Chien-Ying; Wang, Cheng-Kai; Chang, Ching-Fang; Lin, Chun-Yu; Chen, Wei-Ju; Lin, Po-Yu; Wu, Han-Chung ; Ma, Nianhan; Lu, Frank Leigh; Lu, Jean | Cells 9(7), 1706 | | | |
2019 | Dengue and Zika virus domain III-flagellin fusion and glycan- masking E antigen for prime-boost immunization. | Lin, H. H.; Yang, S. P.; Tsai, M. J.; Lin, G. C.; Wu, H. C. ; Wu, S. C. | Theranostics 9(16), 4811-4826 | | | |
2023 | Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants | Sun, CP ; Chiu, CW; Wu, PY; Tsung, SI; Lee, IJ; Hu, CW; Hsu, MF; Kuo, TJ; Lan, YH; Chen, LY; Ng, HY; Chung, MJ; Liao, HN; Tseng, SC; Lo, CH; Chen, YJ; Liao, CC ; Chang, CS; Liang, JJ; Draczkowski, P; Puri, S; Chang, YC ; Huang, JS; Chen, CC; Kau, JH; Chen, YH ; Liu, WC ; Wu, HC ; Hsu, STD ; Wang, IH ; Tao, MH | Molecular Therapy 31(11), 3322-3336 | | | |
2019 | Development of antibody-based theranostics for treatment of cancer | Wu, H. C. | | | | |
2019 | Development of Targeting Nanoparticles for Cancer Molecular Imaging and Therapy | Wu. H.C. | | | | |
2020 | Development of therapeutic antibodies for the treatment of diseases | Ruei-Min Lu ; Yu-Chyi Hwang; I-Ju Liu; Chi-Chiu Lee; Han-Zen Tsai; Hsin-Jung Li; Han-Chung Wu | Journal of Biomedical Science 27, 1 | | | |
2021 | Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function | Yang, TJ; Yu, PY; Chang, YC ; Liang, KH; Tso, HC; Ho, MR ; Chen, WY; Lin, HT; Wu, HC ; Hsu, STD | NATURE STRUCTURAL & MOLECULAR BIOLOGY 28, 731-739 | | | |
2021 | ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling-Driven Epithelial-to-Mesenchymal Transition | Li, H. J.; Ke, F. Y.; Lin, C.C.; Lu, M. Y.; Kuo, Y. H.; Wang, Y. P.; Lin, S. C.; Chang, Y. H.; Chen, H. Y. ; Yang, P. C. ; Wu, H. C. | Cancer research 81(15), 4094-4109 | | | |